These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 16764778)
1. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance]. Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778 [TBL] [Abstract][Full Text] [Related]
2. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946 [TBL] [Abstract][Full Text] [Related]
3. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609 [TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer. Miyata Y; Sakai H; Hayashi T; Kanetake H Prostate; 2003 Feb; 54(2):125-32. PubMed ID: 12497585 [TBL] [Abstract][Full Text] [Related]
5. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging. Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354 [TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
7. [Loss of imprinting of insulin-like growth factor II gene in acute myeloid leukemia]. Liu Y; Yang B; Zhu H; Wang J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):39-41. PubMed ID: 10653908 [TBL] [Abstract][Full Text] [Related]
10. [In situ hybridization to detect the mRNA for insulin-like growth factor-I and II in the prostate]. Deng F; Zhao X; Gu F Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):748-50. PubMed ID: 9590778 [TBL] [Abstract][Full Text] [Related]
11. [The expression and imprinting status of insulin-like growth factor 2 gene in colorectal cancer]. Zhang FR; He XB; Yang YH; Xie W Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):31-4. PubMed ID: 12579496 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684 [TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of insulin-like growth factor II is associated with increased risk of proximal colon cancer. Liou JM; Wu MS; Lin JT; Wang HP; Huang SP; Chiu HM; Lee YC; Lin YB; Shun CT; Liang JT Eur J Cancer; 2007 May; 43(8):1276-82. PubMed ID: 17382534 [TBL] [Abstract][Full Text] [Related]
14. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium. Sutherland BW; Knoblaugh SE; Kaplan-Lefko PJ; Wang F; Holzenberger M; Greenberg NM Cancer Res; 2008 May; 68(9):3495-504. PubMed ID: 18451178 [TBL] [Abstract][Full Text] [Related]
15. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526 [TBL] [Abstract][Full Text] [Related]
16. Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization. Gallagher EM; O'Shea DM; Fitzpatrick P; Harrison M; Gilmartin B; Watson JA; Clarke T; Leonard MO; McGoldrick A; Meehan M; Watson C; Furlong F; O'Kelly P; Fitzpatrick JM; Dervan PA; O'Grady A; Kay EW; McCann A Clin Cancer Res; 2008 Nov; 14(21):6829-38. PubMed ID: 18980977 [TBL] [Abstract][Full Text] [Related]
17. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Risch HA; Puopolo M; Yu H Clin Cancer Res; 2006 Feb; 12(4):1208-14. PubMed ID: 16489075 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors. Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412 [TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma. Hattori H; Matsuzaki A; Suminoe A; Ihara K; Eguchi M; Tajiri T; Suita S; Ishii E; Hara T Cancer; 2000 May; 88(10):2372-7. PubMed ID: 10820361 [TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]